You are here: Industry Insights > NICE

News List

NICE green light for Lilly’s psoriasis drug pharmatimes
April 27, 2017
Patients with plaque psoriasis should be able to get routine access to Eli Lilly’s Taltz on the NHS within the next three months if they meet certain eligibility criteria.
NICE nod for Novartis’ Cosentyx in PsA pharmatimes
April 19, 2017
The National Institute for Health and Care Excellence (NICE) has published a positive Final Appraisal Determination (FAD) which backs NHS use ...
Charities unite to oppose NICE rare disease rules pharmaphorum
March 29, 2017
Nearly 200 rare disease patient groups have come together to call on NICE and NHS England to reconsider plans for a new cost-effectiveness threshold for rare disease drugs.
Final NICE no for Shire’s pancreatic cancer drug pharmatimes
March 29, 2017
Pancreatic cancer patients will not be able to get routine access to Shire’s Onivyde on the National Health Service following a final rejection from cost regulators.
NICE backs use of drugs for breast cancer prevention pharmatimes
March 24, 2017
The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.
NICE recommends liver disease drug europeanpharmaceuticalreview
March 22, 2017
NICE has published draft guidance which recommends Ocaliva, also known as obeticholic acid, for people with the chronic liver disease known as primary biliary cholangitis (PBC).
NICE rejects use of daratumumab (darzalex) monotherapy for treatment of myeloma pharmaceutical-technology
March 21, 2017
he UK National Institute for Health and Care Excellence (NICE) has issued draft negative guidance on anti-cancer drug...
NICE set to reject Janssen’s Darzalex for multiple myeloma pharmatimes
March 20, 2017
Janssen said it is extremely concerned that the National Institute for Health and Care Excellence (NICE) has not ...
UK NICE Board approves changes to drug evaluation process pharmaceutical-technology
March 20, 2017
The UK National Institute for Health and Care Excellence (NICE) board has approved changes to the drug evaluation process.
New NICE rules designed to speed access to the most cost-effective drugs come under fire firstwordpharma
March 17, 2017
A new evaluation process to be introduced April 1 by the National Institute for Health and Care Excellence to speed up the availability of the most cost-effective drugs is being criticised by pharmaceutical companies and some charities.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 41 42 Next page